Skip to main content
SpringerLink
Log in

Hämostaseologie

  • Conference paper
Verhandlungen der Deutschen Gesellschaft für innere Medizin

Part of the book series: Verhandlungen der Deutschen Gesellschaft für innere Medizin ((VDGINNERE,volume 89))

  • 24 Accesses

Zusammenfassung

Veränderungen des Aggregationsverhaltens und der TZ-Überlebenszeit bei Patienten mit KHK wurden von Mehta et al. (1980) mit einer gesteigerten Endoperoxidsynthese der TZ in Zusammenhang gebracht. Hirsh et al. (1981) und Tada et al. (1981) haben bei KHK im Anschluß an durch atriale Stimulation induzierte Angina pectoris erhöhte Thromboxanwerte im Koronarsinus gemessen. Unter der Fragestellung, ob bei KHK Veränderungen der Aktivitäten der an der Thromboxansynthese beteiligten Enzymsysteme in den TZ bestehen, haben wir den Stoffwechsel exogener 14-C-Arachidonsäure untersucht. Außerdem wurde die TZ-Aggregation nach Kollagen und die dadurch induzierte TXB2-Synthese sowie die Prostazyklinsensitivität der TZ bestimmt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • D’Angelo V, Villa S, Mysliciec M, Donati MB, De Gaetano G (1978) Defective fibrinolytic and prostacyclin-like activity in human atheromatous plaques. Thromb Haemostas 39:535–536

    Google Scholar 

  • Greenwald JE, Alexander MS, van Rollins M, Wong LK, Bianchine JR (1981) Argentation thin layer chromatography of arachidonic acid metabolites isolated from human platelets. Prostaglandins 21:33–36

    Article  PubMed  CAS  Google Scholar 

  • Hirsh PD, Hillis HD, Campbell WB, Firth BG, Willerson JT (1981) Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N Engl J Med 304: 685–691

    Article  PubMed  CAS  Google Scholar 

  • Menta J, Mehta P, Conti CR (1980) Platelet function in coronary heart disease. Am J Cardiol 46:943–947

    Article  Google Scholar 

  • Smith JB, Ingerman CM, Silver J (1976) Malondialdehyde formation as an indicator prostaglandin production by human platelets. J Lab Clin Med 88: 167–172

    PubMed  CAS  Google Scholar 

  • Tada M, Kuzuya T, Inoue M, Kodama K, Mishima M, Yamada M, Inui M, Abe H (1981) Elevation of thromboxane B2 levels in patients with classic and variant angina pectoris. Circulation 64:1107–1112

    Article  PubMed  CAS  Google Scholar 

Literatur

  1. Bertele V, Cherletti C, Schieppati A, Di Minno G, De Gaetano G (1981) Inhibiton of thromboxane synthetase does not necessarily prevent platelet aggregation. Lancet 1:1057–1058

    Article  CAS  Google Scholar 

  2. Born GVR (1962) Quantitative investigations into the aggregation of blood platelets. J Physiol (Lond) 162: 67P–68P

    Google Scholar 

  3. Gorman RR (1979) Modulation of human platelet function by prostacyclin and thromboxane A2. Fed Proc 38:83–88

    PubMed  CAS  Google Scholar 

  4. Hamberg M, Svensson J, Samuelsson B (1975) Thromboxanes: A new group of biological aktive compounds derived from prostaglandin endoper-oxides. Proc Natl Acad Sci USA 72: 2994–2998

    Article  PubMed  CAS  Google Scholar 

  5. Moncada S, Higgs EA, Vane JR (1977) Human arterial and venous tissues generate prostacyclin (prostaglandin X), a potent inhibitor of platelet aggregation. Lancet 1:18–21

    Article  PubMed  CAS  Google Scholar 

  6. Okuma M, Steiner M, Baldini M (1970) Studies on lipid peroxides in platelets. I. Method of assay and effect of storage. J Lab Clin Med 283–296

    Google Scholar 

  7. Silver MJ, Smith JB, Ingermann C, Kocsis JJ (1973) Arachidonic acid-induced human platelet aggregation and prostaglandin formation. Prostaglandins 4:863–875

    Article  PubMed  CAS  Google Scholar 

  8. Steinhauer HB, Hertting G (1981) Lowering of the convulsive threshold by non-steroidal anti-inflammatory drugs. Eur J Pharmacol 69:199–203

    Article  PubMed  CAS  Google Scholar 

  9. Steinhauer HB, Lubrich I, Sczesny CM, Schollmeyer P (1982) Effect of different inhibitors of thromboxane synthetase on human platelet behaviour. V. Intern Conference on Prostaglandins, Florence, May 18–21, 1982. Abstract book. Abstract 779

    Google Scholar 

  10. Steinhauer HB, Lubrich I, Schollmeyer P (1982) Wirkung von endogenem Thromboxan A2 und Prostaglandin E2 auf die spontane Thrombozytenaggregation in vitro. In: van de Loo J, Asbeck F (Hrsg) Hämostase, Thrombophilie und Arteriosklerose. Schattauer, Stuttgart New York S 500–503

    Google Scholar 

  11. Steinhauer HB, Lubrich I, Günter M, Schollmeyer P (1983) Response of human platelets to inhibition of thromboxane synthesis. Clin Hemorheol 3: 1–12

    CAS  Google Scholar 

  12. Takayama H, Okuma M, Uchino H (1980) A simple method for estimation of lipoxigenase and cyclo-oxigenase pathways in human platelets — the use of thiobarbituric acid reaction. Thromb Haemostas 44: 111–114

    CAS  Google Scholar 

Literatur

  1. Camussi G et al. (1981) Release of platelet-activating factor in human pathology. Lab Invest 44: 241–251

    PubMed  CAS  Google Scholar 

  2. Demopoulos CA et al. (1979) Platelet-activating factor. J Biol Chem 254: 9355–9358

    PubMed  CAS  Google Scholar 

  3. Czarnetzki BM, Muramatsu T (1981) Saturated and unsaturated l-0-alkyl-2-0-acetoyl-sn-glyce-ro-3-phosphocholines derived from ratfish liver oil: effect on human leucocyte migration. Chem Phys Lipids 29:309–315

    Article  PubMed  CAS  Google Scholar 

  4. Muramatsu T et al. (1981) A facile method for the prepation of l-0-alkyl-2-0-acetoyl-sn-glycero-3-phosphocholines (platelet-activating factor). Chem Phys Lipids 29:121–127

    Article  CAS  Google Scholar 

  5. McManus LM et al. (1980) Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (ACGEPC), a synthetic platelet-activating factor (PAF) in the rabbit. J Immunol 124:2919

    PubMed  CAS  Google Scholar 

  6. Born GV, Cross MJ (1963) The aggregation of blood platelets. J Physiol 168:178–195

    PubMed  CAS  Google Scholar 

Literatur

  • Chesebro JH, Clements IP, Fuster V, Elveback LR, Smith HC, Bardsley WT, Frye RL, Holmes DR, Vlietstra RE, Pluth JR, Wallace RB, Puga FJ, Orszulak TA, Piehler JM, Schaff HV, Danielson GK (1982) A plateletinhibitor-drug trial in coronary-artery bypass operations. N Engl J Med 307: 73–78

    Article  PubMed  CAS  Google Scholar 

  • Born GVR (1962) Aggregation of blood platelets by adenosin diphosphate and its reversal. Nature 194:927–929

    Article  PubMed  CAS  Google Scholar 

  • Hamberg M, Svenson J, Samuelson B (1975) Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 72: 2994–2998

    Article  PubMed  CAS  Google Scholar 

  • Lorenz R, Siess W, Weber PC (1981) Effects of very low versus standard dose acetyl salicylic acid, dipyridamole and sulfinpyrazone on platelet function and thromboxane formation in man. Eur J Pharmacol 70: 511–518

    Article  PubMed  CAS  Google Scholar 

  • Moncada S, Gryglewski R, Bunting S, Vane JR (1976) An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263:663–665

    Article  PubMed  CAS  Google Scholar 

  • Moncada S, Vane JR (1978) Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis. Br Med Bull 34: 129–139

    PubMed  CAS  Google Scholar 

  • O’Brien JR (1968) Aspirin and platelet aggregation. Lancet 1: 204–205

    Article  Google Scholar 

  • O’Grady J, Moneada S (1978) Aspirin: A paradoxical effect on bleeding time. Lancet 4: 780

    Article  Google Scholar 

  • Pantely GA, Goodnight SH, Rahimtoola SH, Harlan BJ, DeMots H, Calvin L, Rösch J (1979) Failure of antiplatelet and anticoagulant therapy to improve patency of grafts after coronary-artery bypass. N Engl J Med 301:962–966

    Article  PubMed  CAS  Google Scholar 

  • Roth GJ, Stanford N, Majerus PW (1975) Acetylation of prostaglandin synthetase by aspirin. Proc Natl Acad Sci USA 72:3073–3076

    Article  PubMed  CAS  Google Scholar 

  • Siess W, Roth P, Weber PC (1981) Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin — a critical evaluation. Thromb Haemostas 45:204–2013;207

    CAS  Google Scholar 

  • Smith JB, Willis AL (1971) Aspirin selectively inhibits prostaglandin production in human platelets. Nature [New Biol] 231:235–237

    CAS  Google Scholar 

  • Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for ASA-like drugs. Nature [New Biol] 231: 232–235

    CAS  Google Scholar 

  • Weksler BB, Pett SB, Alonso D, Richter RC, Stelzer P, Subramanian V, Tack-Goldman K, Gay WA (1983) Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients. N Engl J Med 308: 800–805

    Article  PubMed  CAS  Google Scholar 

Literatur

  1. Horstmann RD, Dietrich M, Bienzle U, Rasche H (1981) Malaria-induced thrombocytopenia. Blut 42:157–164

    Article  PubMed  CAS  Google Scholar 

  2. Horstmann RD, Rasche H, Bienzle U, Dietrich M (1982) Untersuchungen zum Faktor VIII-Komplex bei Malaria. In: van der Loo J, Asbeck F (Hrsg) Hämostase, Thrombophilie und Arteriosklerose. Schattauer, Stuttgart, S 427

    Google Scholar 

Literatur

  1. Ollenschläger G, Gofferje H, Horbach L, Prestele H, Schultis K (1981) Postaggressionsstoffwechsel nach Herzinfarkt — dargestellt am Verhalten kurzlebiger Plasmaproteine. Klin Wochenschr 59:437–449

    Article  PubMed  Google Scholar 

  2. Oehler G, Büdinger M, Heinrich D, Schöndorf T (1983) Das Verhalten von Plasmaproteinen bei Herzinfarktpatienten mit enteraler und parenteraler Ernährung. Wiss. Kongreß der Deutschen Gesellschaft für Ernährung, 28./29. 3. 1983 in Gießen

    Google Scholar 

  3. Thaler E, Lechner K (1981) Antithrombin III deficiency and thromboembolism. Clin Haematol 10: 369

    PubMed  CAS  Google Scholar 

  4. Hedner U, Nilsson IM (1973) Antithrombin III in clinical material. Thrombos Res 3:631

    Article  CAS  Google Scholar 

  5. Ødegard OR, Lie M, Abildegaard U (1975) Heparin cofactor activity measured with an amidolytic method. Thrombos Res 6: 287–294

    Article  Google Scholar 

  6. Owens MR, Miller LL (1980) Net biosynthesis of antithrombin III by the isolated rat liver perfused 12–24 hours. Compared with rat fibrinogen and α2 (acute-phase) globulin, antithrombin III is not an acute phase protein. Biochim Biophys Acta 627: 30

    Article  PubMed  CAS  Google Scholar 

  7. Feldschuh J, Yuceoglu JZ (1975) Study of daily caloric intake of patients in the coronary intensive care unit. Angiology 26:334

    Article  PubMed  CAS  Google Scholar 

  8. Oehler G, Reinhold L, Trüschler A, Schöndorf TH (1982) Antithrombin III-Verminderung unter katabolen Bedingungen. In: van de Loo J, Asbeck F (Hrsg) Hämostase, Thrombophile und Arteriosklerose. IL Kongreß für Thrombose und Hämostase, Münster, Schattauer, Stuttgart, S 651

    Google Scholar 

  9. Jiménez RA, Ingram GIC, Vargas W (1979) Antithrombins in childhood malnutrition. Thromb Haemostas 42:128

    Google Scholar 

  10. Eckle A (1982) Antithrombin III bei parenteraler Ernährung. Diagnostik und Intensivtherapie 15: 365

    Google Scholar 

  11. Forster FJ (1980) Heparin insensitivity after prolonged total parenteral nutrition — probable acquired deficiency of antithrombin III. JAMA 244: 271

    Article  PubMed  CAS  Google Scholar 

  12. Bick RL, Dukes FL, Wilson WL, Fekete LF (1977) Antithrombin III (AT III) as a diagnostic aid in disseminated intravascular coagulation. Thromb Res 10: 721

    Article  PubMed  CAS  Google Scholar 

  13. Cullmann W, Dick W, Müller N (1981) Verhalten des Heparincofaktors (Antithrombin III) bei Patienten mit tiefer Venenthrombose. Inn Med 8:235

    Google Scholar 

Literatur

  1. Bult H, Beetens J, Herman AG (1980) Blood levels of 6-oxo-prostaglandin F1α during endotoxin-induced hypotension in rabbits. Eur J Pharmacol 63:47–56

    Article  PubMed  CAS  Google Scholar 

  2. Cook JA, Wise WC, Halushka PV (1980) Elevated thromboxane levels in the rat during endotoxic shock. Protective effects of imidazole, 13-azaprostanoic acid, or essential fatty acid deficiency. J Clin Invest 65: 227–230

    Article  PubMed  CAS  Google Scholar 

  3. Des Prez RM, Horowitz HI, Hook EW (1961) Effects of bacterial endotoxin on rabbit platelets. J Exp Med 114: 857–873

    Article  Google Scholar 

  4. Ditter H, Matthias FR, Heinrich D, Walter P, Voss R (1982) Auswirkungen einer Prostazyklininfusion auf die Plasmakonzentration der Prostaglandinmetaboliten TXB2 und 6-keto-PGF1α sowie der Plättcheninhaltsstoffe β-Thromboglobulin und Plättchenfaktor 4. Verh Dtsch Ges Inn Med 88: 1150–1153

    Google Scholar 

  5. Ditter H, Matthias FR, Sattler EL (1982) Thromboxanbildung während der Aggregation von plättchenreichem Plasma in Abhängigkeit von Art und Dosis des Stimulans. In: Van de Loo J, Asbeck F (Hrsg) Hämostase, Thrombophilie und Arteriosklerose. Schattauer, Stuttgart, S 493–499

    Google Scholar 

  6. Harris RH, Zmudka M, Maddox Y, Ramwell PW, Fletcher JR (1980) Relationship of TXB2 and 6-keto PGF1β to the hemodynamic changes during baboon endotoxin shock. In: Samuelsson B, Ramwell PW, Paoletti R (eds) Advances in prostaglandin and thromboxane research, vol 7. Raven Press, New York, pp 843–849

    Google Scholar 

  7. Hawiger J, Hawiger A, Timmons S (1975) Endotoxin-sensitive membrane component of human platelets. Nature 256:125–127

    Article  PubMed  CAS  Google Scholar 

  8. Krausz MM, Utsunomiya T, Feuerstein G, Wolfe JHN, Shepro D, Hechtman HB (1981) Prostacyclin reversal of lethal endotoxemia in dog. J Clin Invest 67:1118–1125

    Article  PubMed  CAS  Google Scholar 

  9. Lefer AM, Tabas J, Smith EF (1980) Salutary effects of prostacyclin in endotoxic shock. Pharmacology 21:206–212

    Article  PubMed  CAS  Google Scholar 

  10. Fletcher JR, Ramwell PW, Harris RH (1981) Thromboxane, prostacyclin and hemodynamic events in primate endotoxin shock. Adv Shock Res 5:143–148

    PubMed  CAS  Google Scholar 

  11. Fletcher JR, Ramwell PW (1978) Lidocain or indomethacin improves survival in baboon endotoxin shock. J Surg Res 24:154–160

    Article  PubMed  CAS  Google Scholar 

  12. Fletcher JR, Ramwell PW (1980) The effects of prostacyclin (PGI2) on endotoxin shock and endotoxin-induced platelet aggregation in dogs. Circ Shock 7: 299–308

    PubMed  CAS  Google Scholar 

  13. Frölich JC, Ogletree M, Peskar BA, Brigham KL (1980) Pulmonary hypertension correlated to pulmonary thromboxane synthesis. In: Samuelsson B, Ramwell PW, Paoletti R (eds) Advances in prostaglandin and thromboxane research, vol 7. Raven Press, New York, pp 745–750

    Google Scholar 

  14. Salzman PM, Salmon JA, Moncada S (1980) Prostacyclin and thromboxane A2 synthesis by rabbit pulmonary artery. J Pharmacol Exp Ther 215: 240–247

    PubMed  CAS  Google Scholar 

  15. Smith ME, Günther R, Gee M, Flynn J, Demling RH (1981) Leucocytes, platelets and thromboxane A2 in endotoxin-induced lung injury. Surgery 90: 102–107

    PubMed  CAS  Google Scholar 

  16. Stuart MJ (1981) Effect of endotoxin on arachidonic acid release and thromboxane B2 production by human platelets. Am J Hematol 11:159–164

    Article  PubMed  CAS  Google Scholar 

  17. Walker RJ, Fletcher JR (1981) Possible contribution of platelets to the pathophysiology of host responses to endotoxin. In: Majde JA, Person RJ (eds) Pathophysiological effects of endotoxin at the cellular level. Alan R. Liss, New York, pp 173–185

    Google Scholar 

  18. Washida S (1978) Endotoxin receptor site. I Binding of endoendotoxin to platelets. Acta Med Okayama 32: 159–167

    PubMed  CAS  Google Scholar 

  19. Webb PJ, Westwick J, Scully MF, Zahavi J, Kakkar VV (1981) Do prostacyclin and thromboxane play a role in endotoxin shock? Br J Surg 68: 720–724

    Article  PubMed  CAS  Google Scholar 

  20. Wise WC, Cook JA, Eller T, Halushka PV (1980) Ibuprofen improves survival from endotoxic shock in the rat. J Pharmacol Exp Ther 215:160–164

    PubMed  CAS  Google Scholar 

Literatur

  1. Carter CJ, Kelton JG, Hirsch J, Cerskus A, Santos AV, Gent M (1982) The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits. Blood 59:1239

    PubMed  CAS  Google Scholar 

  2. Kakkar VV, Lawrence D, Bentley PG, De Haas HA, Ward VP, Scully MF (1978) A comparative study of low doses heparin and a heparin analogue in the prevention of postoperative deep vein thrombosis. Thromb Res 13: 111

    Article  PubMed  CAS  Google Scholar 

  3. Lane DA, Michalski R, Van Ross ME, Kakkar VV (1977) Comparison of heparin and a semi-synthetic heparin analogue, A 73025. Br J Haematol 37:239

    Article  PubMed  CAS  Google Scholar 

  4. Michalski R, Lane DA, Kakkar W (1977) Comparison of heparin and a semi-synthetic heparin analogue, A 73025. Br J Haematol 37:247

    Article  PubMed  CAS  Google Scholar 

  5. Zimmermann R, Hof M, Andrassy K (1978) Untersuchungen zur Thrombenbildung unter maximaler Hemmung der Thrombozytenfunktion. In: Breddin HK (Hrsg) Prostaglandine und Plättchenfunktion. Schattauer, Stuttgart, S 355

    Google Scholar 

  6. Zimmermann R, Zeltsch C, Lange D (1979) Estimation of thrombus formation by labeling of platelets, red cells and fibrinogen in experimental thrombosis. Thromb Res 16: 147

    Article  PubMed  CAS  Google Scholar 

  7. Zimmermann R, Thiessen M, Mori H, Weckesser G (1979) The paradoxical thrombogenic effect of aspirin in experimental thrombosis. Thromb Res 16:843

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abt. II, Deutschland

    K. Jaschonek & W. Daiss

  2. Abt. III, Med. Univ.-Klinik Tübingen, Deutschland

    K. R. Karsch

  3. Abt. Biochemie, Fa. Thomae, Biberach, Deutschland

    H. Weissenberger

  4. Abt. II, Med. Univ.-Klinik Tübingen, Deutschland

    P. Ostendorf

  5. Med. Klinik der Univ. Freiburg, Deutschland

    H. B. Steinhauer, B. Günter, I. Lubrich & P. Schollmeyer

  6. Med. Poliklinik der Univ. München, Deutschland

    R. Korth, I. Hillmar & N. Zöllner

  7. Bundesanstalt für Fettforschung, Inst. für Biochemie und Technologie, Münster, Deutschland

    T. Muramatsu

  8. Med. Klinik Innenstadt der Univ. München, Deutschland

    R. Lorenz, C. von Schacky, W. Meister, M. Weber, J. Kotzur, K. Theisen & P. C. Weber

  9. Univ.-Klinik Großhadern, München, Deutschland

    B. Reichart (Herzchirurg.)

  10. Tropeninst. Hamburg und Research Inst. of Scripps Clinic, La Jolla, Californien, USA

    R. D. Horstmann

  11. Zentrum für Innere Medizin, Univ. Ulm, Deutschland

    H. Rasche

  12. Tropeninst. Hamburg, Deutschland

    M. Dietrich

  13. Zentrum für Innere Medizin Gießen, Deutschland

    G. Oehler, M. Büdinger, D. Heinrich & T. Schöndorf

  14. Zentrum für Innere Medizin Gießen, Deutschland

    H. Ditter, F. R. Matthias & D. Reitz

  15. Med. Univ.-Klinik Heidelberg, Deutschland

    R. Zimmermann, J. Caballero, J. Harenberg & E. Walter

Authors
  1. K. Jaschonek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Daiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. R. Karsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Weissenberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P. Ostendorf
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H. B. Steinhauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. B. Günter
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. I. Lubrich
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. P. Schollmeyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. R. Korth
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. I. Hillmar
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. T. Muramatsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. N. Zöllner
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. R. Lorenz
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. C. von Schacky
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. W. Meister
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. M. Weber
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. J. Kotzur
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. B. Reichart
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. K. Theisen
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. P. C. Weber
    View author publications

    You can also search for this author in PubMed Google Scholar

  22. R. D. Horstmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  23. H. Rasche
    View author publications

    You can also search for this author in PubMed Google Scholar

  24. M. Dietrich
    View author publications

    You can also search for this author in PubMed Google Scholar

  25. G. Oehler
    View author publications

    You can also search for this author in PubMed Google Scholar

  26. M. Büdinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  27. D. Heinrich
    View author publications

    You can also search for this author in PubMed Google Scholar

  28. T. Schöndorf
    View author publications

    You can also search for this author in PubMed Google Scholar

  29. H. Ditter
    View author publications

    You can also search for this author in PubMed Google Scholar

  30. F. R. Matthias
    View author publications

    You can also search for this author in PubMed Google Scholar

  31. D. Reitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  32. R. Zimmermann
    View author publications

    You can also search for this author in PubMed Google Scholar

  33. J. Caballero
    View author publications

    You can also search for this author in PubMed Google Scholar

  34. J. Harenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  35. E. Walter
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Kliniken der Landeshauptstadt Wiesbaden, Wiesbaden, D-6200, Deutschland

    Bernhard Schlegel

Rights and permissions

Reprints and permissions

Copyright information

© 1983 J. F. Bergmann Verlag, München

About this paper

Cite this paper

Jaschonek, K. et al. (1983). Hämostaseologie. In: Schlegel, B. (eds) Verhandlungen der Deutschen Gesellschaft für innere Medizin. Verhandlungen der Deutschen Gesellschaft für innere Medizin, vol 89. J.F. Bergmann-Verlag. https://doi.org/10.1007/978-3-642-85456-9_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85456-9_21

  • Publisher Name: J.F. Bergmann-Verlag

  • Print ISBN: 978-3-8070-0335-1

  • Online ISBN: 978-3-642-85456-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation